Persistence of antibodies after a single dose of Tdap vaccine (tetanus, diphtheria, and 5-
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …

Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and
five-component acellular pertussis vaccine for use in individuals past childhood) was …

Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …

Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …

In a clinical trial, adolescents who had received a booster dose of reduced dose diphtheria–
tetanus-5-component acellular pertussis vaccine (Adacel®, Tdap) 5 years earlier maintained …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …

The duration of protection after vaccination with reduced antigen content diphtheria, tetanus
and acellular pertussis vaccines (Tdap) is not known. Long-term post-vaccination …

Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …

Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …